Comparisons of Insulin Resistance- and Steatosis-Based Scores in Monitoring Metabolic Associated Fatty Liver Disease Treatment Response
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparisons of Insulin Resistance- and Steatosis-Based Scores in Monitoring Metabolic Associated Fatty Liver Disease Treatment Response
Authors
Keywords
-
Journal
ANNALS OF NUTRITION AND METABOLISM
Volume -, Issue -, Pages 1-12
Publisher
S. Karger AG
Online
2023-09-08
DOI
10.1159/000530531
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ability of lipoprotein (a) level to predict early carotid atherosclerosis is impaired in patients with advanced liver fibrosis related to metabolic associated fatty liver disease
- (2022) Tingfeng Wu et al. Clinical and Translational Gastroenterology
- Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population
- (2021) Qing Zhang et al. BMC GASTROENTEROLOGY
- Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B
- (2021) Jiaxuan Zhang et al. Frontiers in Microbiology
- Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: a propensity score-matched analysis
- (2021) Joonho Jeong et al. Clinical and Molecular Hepatology
- Precise fibrosis staging with shear wave elastography in chronic hepatitis B depends on liver inflammation and steatosis
- (2020) Junzhao Ye et al. Hepatology International
- The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study
- (2020) Takuro Okamura et al. Clinics and Research in Hepatology and Gastroenterology
- NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
- (2020) Amélio F. Godoy-Matos et al. Diabetology & Metabolic Syndrome
- Change in MRI-PDFF and Histologic Response in Patients with Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
- (2020) Jonathan G. Stine et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus
- (2020) Manoj Kumar Sarma et al. MAGNETIC RESONANCE IMAGING
- MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
- (2020) Rohit Loomba HEPATOLOGY
- Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
- (2019) Jiulian Gu et al. EUROPEAN RADIOLOGY
- Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Veeral Ajmera et al. GASTROENTEROLOGY
- Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet
- (2018) Stefan Kabisch et al. Nutrients
- Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
- (2018) Purificación Cid‐Silva et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery
- (2018) Roy Taylor et al. Cell Metabolism
- Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
- (2018) Yao Yu et al. Advanced Science
- Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3
- (2017) Chengliang Zhu et al. Lipids in Health and Disease
- NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1 H-MRS?
- (2017) Shelley E. Keating et al. LIVER INTERNATIONAL
- Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease
- (2016) Yoosoo Chang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis
- (2015) Ahilan Arulanandan et al. Clinical Gastroenterology and Hepatology
- HBV inhibits apoB production via the suppression of MTP expression
- (2011) Fu-Bing Wang et al. Lipids in Health and Disease
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
- (2009) Anna Kotronen et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started